- Report
- January 2025
- 146 Pages
Global
From €3538EUR$3,950USD£3,016GBP
- Report
- May 2025
- 184 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- August 2024
- 140 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- April 2025
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- February 2025
- 180 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- October 2024
- 120 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2025
- 73 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 172 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 66 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 146 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- June 2025
- 89 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- May 2025
- 182 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- April 2025
- 150 Pages
United States
From €5329EUR$5,950USD£4,543GBP
- Report
- April 2025
- 85 Pages
United States
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3465EUR$3,869USD£2,954GBP
- Report
- December 2024
- 131 Pages
North America
From €3045EUR$3,400USD£2,596GBP
€3583EUR$4,000USD£3,054GBP
- Report
- December 2024
- 184 Pages
Africa, Middle East
From €1344EUR$1,500USD£1,145GBP
- Report
- September 2023
- 167 Pages
Global
From €4165EUR$4,650USD£3,550GBP
- Report
- June 2023
- 175 Pages
Global
From €5329EUR$5,950USD£4,543GBP

Bioequivalence is a term used in biotechnology to describe the similarity between two pharmaceutical products. It is used to assess the interchangeability of two products, such as generic and brand-name drugs, and to ensure that they have the same therapeutic effect. Bioequivalence studies are conducted to compare the pharmacokinetic properties of two products, such as their absorption, distribution, metabolism, and excretion. The results of these studies are used to determine whether the two products are therapeutically equivalent and can be used interchangeably.
The bioequivalence market is a rapidly growing sector of the biotechnology industry. It is driven by the increasing demand for generic drugs, as well as the need for regulatory compliance. Companies in this market provide services such as bioequivalence studies, pharmacokinetic analysis, and regulatory consulting.
Some companies in the bioequivalence market include Parexel, Covance, Quintiles, and PPD. Show Less Read more